{
  "documentMetadata": {
    "title": "Community-acquired pneumonia in infants and children, age > 3 months",
    "sourceFile": "Pneumonia, Children, Age gt 3 months.pdf",
    "lastUpdated": "2024-12-19"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Community-acquired pneumonia in infants and children, age > 3 months.",
        "Empiric therapy for presumed bacterial pneumonia. Viral etiology is more common that bacterial overall even among hospitalized children N Engl J Med 372:845 2014.",
        "Consider influenza virus, RSV (respiratory syncytial virus), human metapneumovirus, parainfluenza virus, adenovirus, SARS-CoV-2.",
        "Influenza testing recommended for all hospitalized children in winter season.",
        "Multiplex viral testing may be useful if it will change infection control or treatment, including avoidance of antibiotics.",
        "Obtain blood culture if hospitalized; Blood cultures have very low yield in non-hospitalized children.",
        "Often of mild to moderate severity."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "RSV",
        "Human metapneumovirus",
        "Influenza",
        "Common \"other\" viruses: rhinovirus, parainfluenza, adenovirus",
        "SARS-CoV-2",
        "Strep. pneumoniae",
        "H. influenzae",
        "Mycoplasma",
        "Group A Streptococcus",
        "Staph. aureus (uncommon)",
        "M. tuberculosis"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Outpatient"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Preferred",
            "components": [
              {
                "drug": "Amoxicillin",
                "dose": "90 mg/kg/day",
                "frequency": "in 2 divided doses x 5 days",
                "notes": "(see Lancet 371:49, 2008)"
              }
            ]
          }
        },
        {
          "type": "paragraph",
          "text": "Antimicrobial therapy is not routinely required for preschool-aged children with community-acquired pneumonia (CAP) because viral pathogens cause most clinical disease."
        },
        {
          "type": "paragraph",
          "text": "If influenza is diagnosed, treatment with oseltamivir or baloxavir is recommended for all children < 5 and those with hight risk conditions"
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Inpatient"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Recommended",
            "condition": "If atypical infection suspected",
            "components": [
              {
                "drug": "Azithromycin",
                "dose": "10 mg/kg",
                "route": "IV",
                "frequency": "day 1, then 5 mg/kg",
                "notes": "(maximum 500 mg/day), (maximum 250 mg)"
              }
            ]
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Recommended",
            "condition": "If community-associated MRSA a concern",
            "components": [
              {
                "drug": "Vancomycin",
                "dose": "60-80 mg/kg",
                "route": "IV",
                "frequency": "divided 3-4 times a day",
                "notes": "to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator; alternative is trough of 10-15 µg/mL but AUC targeting is preferred)",
                "connector": "or"
              },
              {
                "drug": "Clindamycin",
                "dose": "40 mg/kg/day",
                "frequency": "divided q6-8h"
              }
            ]
          }
        },
        {
          "type": "paragraph",
          "text": "Negative nasal PCR test for MRSA makes MRSA pneumonia highly unlikely"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Recommended",
            "condition": "If influenza is diagnosed or strongly suspected",
            "components": [
              {
                "drug": "Oseltamivir"
              }
            ]
          }
        },
        {
          "type": "list",
          "items": [
            "Wt > 15 kg to 23 kg: 45 mg in 2 doses x 5 days",
            "Wt 23 kg to 40 kg: 60 mg in 2 doses x 5 days",
            "Wt > 40 kg: 75 mg in 2 doses x 5 days"
          ]
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Recommended",
            "appliesTo": {
              "description": "Infants 2 wks-11 months"
            },
            "components": [
              {
                "drug": "Oseltamivir",
                "dose": "3 mg/kg",
                "frequency": "in 2 doses x 5 days"
              }
            ]
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Recommended",
            "condition": "Fully immunized and bacterial infection suspected",
            "components": [
              {
                "drug": "Ampicillin",
                "dose": "150-200 mg/kg/day",
                "route": "IV",
                "frequency": "divided q6h"
              }
            ]
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Recommended",
            "condition": "Not fully immunized and bacterial infection suspected OR life-threatening illness",
            "components": [
              {
                "drug": "Cefotaxime",
                "dose": "150 mg/kg/day",
                "route": "IV",
                "frequency": "divided q8h",
                "notes": "(where available outside the US)",
                "connector": "or"
              },
              {
                "drug": "Ceftriaxone",
                "dose": "75-100 mg/kg/day",
                "route": "IV",
                "frequency": "once daily"
              }
            ]
          }
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Outpatient"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Alternative",
            "components": [
              {
                "drug": "Azithromycin",
                "dose": "10 mg/kg",
                "route": "po",
                "frequency": "x 1 dose (maximum 500 mg), then 5 mg/kg (maximum 250 mg) po x 4 days",
                "notes": "(for true amoxicillin allergy or suspected or proven atypical pathogen)"
              },
              {
                "drug": "Amoxicillin-clavulanate",
                "dose": "90 mg/kg/day",
                "notes": "(amoxicillin component)"
              },
              {
                "drug": "Clarithromycin",
                "dose": "15 mg/kg/day",
                "frequency": "in 2 divided doses x 7-14 days"
              }
            ]
          }
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Inpatient, fully immunized"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Alternative",
            "components": [
              {
                "drug": "Cefotaxime",
                "dose": "150 mg/kg/day",
                "route": "IV",
                "frequency": "divided q8h",
                "notes": "(where available)"
              },
              {
                "drug": "Ceftriaxone",
                "dose": "75-100 mg/kg/day",
                "route": "IV",
                "frequency": "once daily"
              }
            ]
          }
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "May transition to oral regimen as early as 2-3 days depending on clinical response",
        "Shorter duration (5-7 days) shown to be equally effective in adults and pediatric outpatients. JAMA Pediatr. 2022 Mar 1;176(3):253",
        "Pediatric data on shorter course for hospitalized children limited. 2011 guidelines still recommend 10-14 days but 5-7 are likely adequate in absence of complicated pneumonia",
        "MRSA therapy can be stopped if nasal PCR for MRSA is negative",
        "Viral causes predominate in children age <5 years. Antibiotics may not be necessary especially if virus detected",
        "Low procalcitonin (<0.25 ng/mL) has high negative predictive value for excluding bacterial disease. J Pediatric Infect Dis Soc. 2017 Feb 3. Antibiotics can usually be stopped.",
        "Longer durations of therapy may be required for methicillin-resistant Staph. aureus (MRSA)",
        "For appropriately drained empyema, treat for 7-10 days after resolution of fever or up to 4-6 weeks"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "IDSA treatment guidelines for treatment of community-acquired pneumonia in infants and children older than 3 months of age: Clin Infect Dis 53:617, 2011; Clin Infect Dis 53:e25, 2011.",
        "Etiology among hospitalized children N Engl J Med 372:845 2014",
        "Vancomycin: traditional dosing of 45-60 mg/kg/day frequently does not achieve target AUC in term infants and older children with normal renal function. Use of AUC24 closer to 400 µg/mL adequate for most non-CNS infections. Clin Infect Dis Jul 13 2020"
      ]
    }
  ]
}